Connor, Clark & Lunn Investment Management (CC&L)
GEN

Connor, Clark & Lunn Investment Management (CC&L)’s Genesis Healthcare, Inc. GEN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-111,173
Closed -$54K – 1143
2020
Q4 		$54K Sell
111,173
-10,070
-8% -$5.09K ﹤0.01% 875
2020
Q3 		$66K Sell
121,243
-14,754
-11% -$10.6K ﹤0.01% 890
2020
Q2 		$94K Sell
135,997
-62,661
-32% -$50.4K ﹤0.01% 957
2020
Q1 		$167K Buy
198,658
+25,586
+15% +$36.6K ﹤0.01% 886
2019
Q4 		$284K Buy
173,072
+12,350
+8% +$18.5K ﹤0.01% 772
2019
Q3 		$178K Buy
160,722
+4,643
+3% +$5.37K ﹤0.01% 879
2019
Q2 		$194K Buy
156,079
+6,874
+5% +$8.75K ﹤0.01% 905
2019
Q1 		$215K Sell
149,205
-13,100
-8% -$19.4K ﹤0.01% 813
2018
Q4 		$192K Buy
162,305
+17,202
+12% +$25.5K ﹤0.01% 856
2018
Q3 		$196K Buy
145,103
+129,228
+814% +$205K ﹤0.01% 851
2018
Q2 		$36K Buy
+15,875
New +$30.7K ﹤0.01% 1016
2016
Q1 		– Sell
-26,800
Closed -$93K – 930
2015
Q4 		$93K Sell
26,800
-4,400
-14% -$21.1K ﹤0.01% 762
2015
Q3 		$191K Buy
+31,200
New +$212K ﹤0.01% 646

Other funds holding GEN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s GEN Position: Q1 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 111,173 shares — an estimated $54K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GEN in Q3 2015 and held it in 13 quarters. The position peaked at $284K in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 111,173 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $54K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Genesis Healthcare, Inc. in Q3 2015 and held it in 13 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Genesis Healthcare, Inc. position peaked at $284K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2021, filed 13 May 2021.